What one share of Eton Pharmaceuticals holds
Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. We currently have eight commercial rare disease products: INCRELEX®, ALKINDI SPRINKLE®, KHINDIVITM, GALZIN®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone.
Eton Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.88 |
|---|---|
| Profit | $0.47 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | $0.54 |
| Cash and investments | $0.95 |
| Debt | $0.67 |
| Book value | $1.65 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$5.80 | $0.04 | −$1.31 | — | — |
| 2019 | — | −$1.03 | $0.06 | −$1.08 | — | $0.59 |
| 2020 | — | −$1.33 | $0.00 | −$1.07 | — | $0.73 |
| 2021 | $0.87 | −$0.08 | $0.00 | −$0.19 | — | $0.72 |
| 2022 | $0.85 | −$0.36 | $0.00 | $0.19 | — | $0.52 |
| 2023 | $1.23 | −$0.04 | $0.00 | $0.27 | — | $0.60 |
| 2024 | $1.51 | −$0.15 | $0.00 | $0.04 | — | $0.91 |
| 2025 | $2.97 | −$0.17 | $0.01 | $0.38 | — | $0.97 |
Common questions about Eton Pharmaceuticals
How much does one share of Eton Pharmaceuticals earn?
Over the last 12 months, each share of Eton Pharmaceuticals earned $0.47 of profit on $3.88 of sales, keeping about 12¢ of every $1 (profit margin).
Does Eton Pharmaceuticals pay a dividend?
Eton Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Eton Pharmaceuticals’s book value per share?
Eton Pharmaceuticals’s book value is $1.65 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Eton Pharmaceuticals have?
Each share of Eton Pharmaceuticals has $0.95 of cash and investments and $0.67 of debt, as of June 30, 2026.
What is Eton Pharmaceuticals’s free cash flow per share?
$0.54 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Eton Pharmaceuticals bought back shares?
Eton Pharmaceuticals’s share count rose about 319% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.